Variant report

Variant	rs1438153
Chromosome Location	chr2:86184027-86184028
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr2:86112745..86122516-chr2:86175080..86185190,27	MCF-7	breast:
2	chr2:86181209..86184209-chr2:86184954..86187247,3	K562	blood:

Variant related genes	Relation type
ENSG00000232504	Chromatin interaction
ENSG00000115525	Chromatin interaction

Extended variants
information (count: 37 )
Associated
traits (count: 1 )

rSNPs within LD-proxies of this variant (count:35)

rs_ID	r²[population]
rs10181091	0.81[AMR][1000 genomes];0.81[EUR][1000 genomes]
rs10181916	0.83[EUR][1000 genomes];0.90[ASN][1000 genomes]
rs10183118	0.81[EUR][1000 genomes]
rs10186005	0.99[AMR][1000 genomes];0.98[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs10189191	0.81[EUR][1000 genomes];0.90[ASN][1000 genomes]
rs10198260	0.88[ASN][1000 genomes]
rs1020095	0.80[EUR][1000 genomes];0.90[ASN][1000 genomes]
rs11890514	0.98[AMR][1000 genomes];0.95[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs11891625	0.98[AMR][1000 genomes];0.98[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs12470643	0.81[AFR][1000 genomes];0.98[AMR][1000 genomes];0.98[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs12472588	0.98[AMR][1000 genomes];0.95[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs12476390	0.98[AMR][1000 genomes];0.95[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs12714161	0.81[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs12714163	0.80[EUR][1000 genomes];0.90[ASN][1000 genomes]
rs12714164	0.80[EUR][1000 genomes];0.88[ASN][1000 genomes]
rs12714165	0.80[EUR][1000 genomes];0.88[ASN][1000 genomes]
rs13000793	0.98[AMR][1000 genomes];0.97[EUR][1000 genomes];0.95[ASN][1000 genomes]
rs13397189	0.81[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs1438155	0.86[AFR][1000 genomes];0.99[AMR][1000 genomes];0.98[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs1561330	0.83[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs1866242	0.98[AMR][1000 genomes];0.97[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs1866243	0.97[AMR][1000 genomes];0.92[EUR][1000 genomes]
rs1866245	0.81[EUR][1000 genomes];0.90[ASN][1000 genomes]
rs4346389	0.81[EUR][1000 genomes];0.90[ASN][1000 genomes]
rs4480982	0.86[ASN][1000 genomes]
rs4514874	0.81[AFR][1000 genomes];0.99[AMR][1000 genomes];0.98[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs4832018	0.80[EUR][1000 genomes];0.88[ASN][1000 genomes]
rs4832020	0.80[EUR][1000 genomes];0.88[ASN][1000 genomes]
rs6547651	0.86[AFR][1000 genomes];0.99[AMR][1000 genomes];0.96[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs6706720	0.89[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs6708525	0.98[AMR][1000 genomes];0.98[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs6713002	0.81[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs6737454	0.86[AFR][1000 genomes];0.99[AMR][1000 genomes];0.98[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs7597264	0.83[ASN][1000 genomes]
rs934830	0.83[EUR][1000 genomes];0.90[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:2 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1001104	chr2:86182021-86271923	Enhancers Weak transcription Strong transcription Genic enhancers ZNF genes & repeats Flanking Active TSS Bivalent Enhancer Active TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	7 gene(s)	inside rSNPs	diseases
2	nsv535807	chr2:86182021-86271923	Strong transcription Enhancers Weak transcription Genic enhancers Flanking Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent Enhancer Active TSS	TF binding region CpG island Chromatin interactive region lncRNA	7 gene(s)	inside rSNPs	diseases

mRNA abundance (count:1)

SNP	Gene	Cis/trans	Tissue	Source
rs1438153	IMMT	Cis_1M	lymphoblastoid	RTeQTL

Chromatin state (count:42 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:86178800-86188200	Enhancers	Fetal Muscle Leg	muscle
2	chr2:86180200-86187600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
3	chr2:86180600-86184200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
4	chr2:86180800-86184400	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
5	chr2:86180800-86188600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
6	chr2:86181000-86186600	Weak transcription	K562	blood
7	chr2:86181800-86184200	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
8	chr2:86181800-86186200	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
9	chr2:86182400-86184400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
10	chr2:86182600-86187600	Weak transcription	Esophagus	oesophagus
11	chr2:86183000-86184200	Enhancers	HMEC	breast
12	chr2:86183000-86184400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
13	chr2:86183000-86184600	Enhancers	Skeletal Muscle Male	skeletal muscle
14	chr2:86183000-86184600	Enhancers	HSMM	muscle
15	chr2:86183000-86184800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
16	chr2:86183200-86184400	Enhancers	Muscle Satellite Cultured Cells	--
17	chr2:86183200-86184600	Enhancers	HSMMtube	muscle
18	chr2:86183400-86184200	Enhancers	Psoas Muscle	Psoas
19	chr2:86183400-86184600	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
20	chr2:86183400-86184600	Enhancers	Skeletal Muscle Female	skeletal muscle
21	chr2:86183400-86184800	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
22	chr2:86183400-86185000	Enhancers	HUES64 Cell Line	embryonic stem cell
23	chr2:86183400-86185200	Weak transcription	Fetal Muscle Trunk	muscle
24	chr2:86183400-86185800	Weak transcription	A549	lung
25	chr2:86183600-86184200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
26	chr2:86183600-86184400	Enhancers	HUES6 Cell Line	embryonic stem cell
27	chr2:86183600-86184600	Enhancers	iPS-18 Cell Line	embryonic stem cell
28	chr2:86183600-86184800	Enhancers	ES-I3 Cell Line	embryonic stem cell
29	chr2:86183600-86184800	Enhancers	iPS-20b Cell Line	embryonic stem cell
30	chr2:86183600-86187600	Weak transcription	Pancreas	Pancrea
31	chr2:86183800-86184200	Enhancers	Dnd41	blood
32	chr2:86183800-86184400	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
33	chr2:86183800-86184600	Enhancers	H1 Cell Line	embryonic stem cell
34	chr2:86183800-86184600	Enhancers	HUES48 Cell Line	embryonic stem cell
35	chr2:86183800-86190800	Weak transcription	Stomach Mucosa	stomach
36	chr2:86184000-86184400	Enhancers	Primary hematopoietic stem cells short term culture	blood
37	chr2:86184000-86184400	Enhancers	NHEK	skin
38	chr2:86184000-86184600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
39	chr2:86184000-86184600	Enhancers	iPS-15b Cell Line	embryonic stem cell
40	chr2:86184000-86184600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
41	chr2:86184000-86184800	Enhancers	ES-WA7 Cell Line	embryonic stem cell
42	chr2:86184000-86184800	Enhancers	H9 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links